Clinical Trial Detail

NCT ID NCT01935336
Title Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive Biomarkers
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Colorado, Denver
Indications

lung cancer

Therapies

Ponatinib

Age Groups: adult

Additional content available in CKB BOOST